NextPoint Could Treat PD-L1 Negative Cancer Patients With HHLA2-Targeted Approach

 
• By Ayisha Sharma
  
Emerging Company Profile: NextPoint Therapeutics
PD-L1 Negative Cancer Patients Have Fewer Treatment Options • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Emerging Company Profiles

More from Start-Ups & SMEs